Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (09989.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

11.8x

EV/EBITDA

13.4x

Market Cap

HKD 6.21B

MomentumView details →

1D Return

−0.59%

YTD Return

−18.81%

RSI (14)

45.0

ValuationView details →

P/E (Fwd)

11.8x

EV/EBITDA

13.4x

Market Cap

HKD 6.21B

RSI (14)

45.0

MomentumView details →

1D Return

−0.59%

YTD Return

−18.81%

ProfitabilityView details →

Gross Margin

33.33%

Net Margin

3.87%

EBITDA Margin

6.71%

ROE (TTM)

1.70%

ROA (TTM)

1.24%

Asset Turnover

0.31x

GrowthView details →

Revenue YoY

−0.37%

EPS YoY

−49.87%

FCF YoY

−19.01%

Revenue CAGR 3Y

−8.53%

EPS CAGR 3Y

−21.70%

EBITDA YoY

−35.31%

EarningsView details →

EPS (Actual)

HKD 0.07

EPS Surprise

−24.68%

Beats (12Q)

0/12

Next Q EPS Est

HKD 0.23

Avg Surprise (4Q)

−24.68%

Rev Surprise

−9.85%

Capital & dividendView details →

Debt/Equity

0.24x

Current Ratio

2.31x

Quick Ratio

1.33x

Div Yield

3.93%

Div Rate

HKD 0.17

Div Growth 1Y

−38.88%

Financials snapshotView financials →

Revenue (TTM)

5.24B

Net Income (TTM)

202.88M

Op. CF (TTM)

1.69B

Next earningsNov 4, 2026 →

Latest newsMore news →

Hepalink announced its H1 2026 results: revenue of 2.58 billion yuan, down 8.44% year-on-year; net profit attributable to shareholders of 275 million yuan, down 34.74% year-on-year; non-GAAP net profit of 162 million yuan, down 62.01% year-on-year. The company plans no cash dividend, no bonus shares, and no capital reserve conversion.8d ago

Similar companies

China Shineway Pharmaceutical Group Limited02877.HK 辰欣药业603367.SH 昆药集团600422.SH 亚虹医药-U688176.SH Lantheus Holdings, Inc.LNTH 华纳药厂688799.SH Find similar companies →

Latest newsMore news →

Hepalink announced its H1 2026 results: revenue of 2.58 billion yuan, down 8.44% year-on-year; net profit attributable to shareholders of 275 million yuan, down 34.74% year-on-year; non-GAAP net profit of 162 million yuan, down 62.01% year-on-year. The company plans no cash dividend, no bonus shares, and no capital reserve conversion.8d ago